Convergent and concurrent validity of the Frankfurt Complaint Questionnaire as a screener for psychosis risk

References

• Boyko, E. J. 1994. “Ruling out or Ruling in Disease with the Most Sensitive or Specific Diagnostic Test: Short Cut or Wrong Turn ?” Medical Decision Making 14 (2): 175–179.10.1177/0272989X9401400210
   PubMed Web of Science ®Google Scholar
• Burn, C. C., and A. A. Weir. 2011. “Using Prevalence Indices to Aid Interpretation and Comparison of Agreement Ratings between Two or More Observers.” The Veterinary Journal 188 (2): 166–170.10.1016/j.tvjl.2010.04.021
   PubMed Web of Science ®Google Scholar
• Burn, C. C., J. C. Pitchard, and H. R. Whay. 2009. “Observer Reliability for Working Equine Walfare Assessment: Problems with High Prevalences of Certain Results.” Animal Walfare 18 (2): 177–187.
   Web of Science ®Google Scholar
• Byrt, T., J. Bishop, and J. B. Carlin. 1993. “Bias, Prevalence and Kappa.” Journal of Clinical Epidemiology 46 (5): 423–429.10.1016/0895-4356(93)90018-V
   PubMed Web of Science ®Google Scholar
• Cadman, D., L. Chambers, W. Feldman, and D. Sackett. 1984. “Assessing the Effectiveness of Community Screening Programs.” JAMA: The Journal of the American Medical Association 251 (12): 1580–1585.10.1001/jama.1984.03340360046028
   PubMed Web of Science ®Google Scholar
• Dawe, S., N. J. Loxton, L. Hide, D. J. Kavanagh, and R. P. Mattick. 2002. Review of Diagnostic Screening Instruments for Alcohol and Other Drug Use and Other Psychiatric Disorders. Commonwealth of Australia, AU. Accessed May 11, 2014. http://immunise.health.gov.au/internet/main/publishing.nsf/Content/EB4EDA7A97F80941CA257BF000199DA8/$File/mono48.pdf
   Google Scholar
• Fusar-Poli, P., S. Borgwardt, A. Bechdolf, J. Addington, A. Riecher-Rössler, F. Schultze-Lutter, M. Keshavan, et al. 2013. “The Psychosis High-risk State: A Comprehensive State-of-the-Art Review.” JAMA Psychiatry 70 (1): 107–120.10.1001/jamapsychiatry.2013.269
   PubMed Web of Science ®Google Scholar
• Fusar-Poli, P., A. R. Yung, P. McGorry, and J. van Os. 2014. “Lessons Learned from the Psychosis High-risk State: Towards a General Staging Model of Prodromal Intervention.” Psychological Medicine 44 (01): 17–24.10.1017/S0033291713000184
   PubMed Web of Science ®Google Scholar
• Fusar-Poli, P., M. Cappucciati, G. Rutigliano, F. Schultze-Lutter, I. Bonoldi, S. Borgwardt, A. Riecher-Rössler, et al. 2015. “At Risk or Not at Risk? Meta-analysis of the Prognostic Accuracy of Psychometric Interviews for Psychosis Prediction.” World Psychiatry 14 (3): 322–332. doi:10.1017/S003329171.
   Google Scholar
• Fux, L., P. Walger, B. G. Schimmelmann, and F. Schultze-Lutter. 2013. “The Schizophrenia Proneness Instrument, Child and Youth Version (SPI-CY): Practicability and Discriminative Validity.” Schizophrenia Research 146 (1–3): 69–78.10.1016/j.schres.2013.02.014
   PubMed Web of Science ®Google Scholar
• Granö, N., M. Karjalainen, A. Itkonen, J. Anto, V. Edlund, M. Heinimaa, and M. Roine. 2011. “Differential Results between Self-report and Interview-based Ratings of Risk Symptoms of Psychosis.” Early Intervention in Psychiatry 5 (4): 309–314.10.1111/eip.2011.5.issue-4
   PubMed Web of Science ®Google Scholar
• Gross, G. 1989. “The ‘Basic’ Symptoms of Schizophrenia.” British Journal of Psychiatry 155 (Suppl 7): 21–25.
   Google Scholar
• Gross, G., G. Huber, J. Klosterkötter, and M. Linz. 1987. Bonner Skala Für Die Beurteilung Von Basisymptomen [BSABS; Bonn Scale for the Assessment of Basic Symptoms]. Berlin: Springer-Verlag.
   Google Scholar
• Hanssen, M., F. Peeters, L. Krabbendam, S. Radstake, H. Verdoux, and J. van Os. 2003. “How Psychotic Are Individuals with Non-psychotic Disorders?” Social Psychiatry and Psychiatric Epidemiology 38 (3): 149–154.10.1007/s00127-003-0622-7
   PubMed Web of Science ®Google Scholar
• Heinimaa, M., R. K. Salokangas, T. Ristkari, M. Plathin, J. Huttunen, T. Ilonen, T. Suomela, J. Korkeila, and T. H. Mcglashan. 2003. “PROD-Screen – A Screen for Prodromal Symptoms of Psychosis.” International Journal of Methods in Psychiatric Research 12 (2): 92–104.10.1002/(ISSN)1557-0657
   PubMed Web of Science ®Google Scholar
• Huber, G. 1966. “Reine Defektsyndrome Und Basisstadien Endogener Psychosen [Pure deficit syndromes and basic stages of endogen psychosis].” Fortschritte Der Neurologie Psychiatrie 34: 409–426.
   Web of Science ®Google Scholar
• Huber, G., and G. Gross. 1989. “The Concept of Basic Symptoms in Schizophrenic and Schizoaffective Psychoses.” Recenti Progressi in Medicina 80 (12): 646–652.
   PubMedGoogle Scholar
• Ising, H. K., W. Veling, R. L. Loewy, M. W. Rietveld, J. Rietdijk, S. Dragt, R. M. Klaassen, et al. 2012. “The Validity of the 16-Item Version of the Prodromal Questionnaire (PQ-16) to Screen for Ultra High Risk of Developing Psychosis in the General Help-seeking Population.” Schizophrenia Bulletin 38 (6): 1288–1296.10.1093/schbul/sbs068
   PubMed Web of Science ®Google Scholar
• Jaeschke, R., G. H. Guyatt, and D. L. Sackett. 1994. “Users’ Guides to the Medical Literature. III. How to use an article about a diagnostic test. B. What are the results and will they help me in caring for my patients?” JAMA 271 (9): 703–707.10.1001/jama.1994.03510330081039
   PubMed Web of Science ®Google Scholar
• Janes, H., and M. S. Pepe. 2008. “Adjusting for Covariates in Studies of Diagnostic, Screening, or Prognostic Markers: An Old Concept in a New Setting.” American Journal of Epidemiology 168 (1): 89–97.10.1093/aje/kwn099
   PubMed Web of Science ®Google Scholar
• Johns, L. C., J. van Os. 2001. “The Continuity of Psychotic Experiences in the General Population.” Clinical Psychology Review 21 (8): 1125–1141.10.1016/S0272-7358(01)00103-9
   PubMed Web of Science ®Google Scholar
• Kline, E., and J. Schiffman. 2014. “Psychosis Risk Screening: A Systematic Review.” Schizophrenia Research 158 (1–3): 11–18.10.1016/j.schres.2014.06.036
   PubMed Web of Science ®Google Scholar
• Klosterkötter, J., M. Hellmich, E. M. Steinmeyer, and F. Schultze-Lutter. 2001. “Diagnosing Schizophrenia in the Initial Prodromal Phase.” Archives of General Psychiatry 58 (2): 158–164.10.1001/archpsyc.58.2.158
   PubMed Web of Science ®Google Scholar
• Konings, M., M. Bak, M. Hanssen, J. van Os, and L. Krabbendam. 2006. “Validity and Reliability of the CAPE: A Self-report Instrument for the Measurement of Psychotic Experiences in the General Population.” Acta Psychiatrica Scandinavica 114 (1): 55–61.10.1111/acp.2006.114.issue-1
   PubMed Web of Science ®Google Scholar
• Lin, A., S. J. Wood, B. Nelson, A. Beavan, P. McGorry, and A. R. Yung. 2015. “Outcomes of Nontransitioned Cases in a Sample at Ultra-high Risk for Psychosis.” American Journal of Psychiatry 172 (3): 249–258.10.1176/appi.ajp.2014.13030418
   PubMed Web of Science ®Google Scholar
• Loas, G., V. Yon, J. L. Monestès, and M. J. Cuesta. 2011. “Test–retest Reliability of the Frankfurt Complaint Questionnaire.” Psychological Reports 108 (2): 503–506.10.2466/02.09.15.PR0.108.2.503-506
   PubMed Web of Science ®Google Scholar
• Maß, R. 2005. “Eppendorf Schizophrenia Inventory (ESI) vs. Frankfurt Complaint Questionnaire (FCQ).” Nervenarzt 76 (9): 1109–1116.
   PubMed Web of Science ®Google Scholar
• Maß, R., K. Hitschfeld, E. Wall, and H. B. Wagner. 1997. “Validität der Erfassung schizophrener Basissymptome [Validity of the measurement of basic symptoms of schizophrenia].” Nervenarzt 68 (3): 205–211.
   PubMed Web of Science ®Google Scholar
• Maß, R., C. Haasen, and K. Wolf. 2000. “Das Eppendorfer Schizophrenie-Inventar (ESI) Entwicklung und Evaluation eines Fragebogens zur Erfassung charakteristischer Selbstwahrnehmungen kognitiver Dysfunktionen schizophren Erkrankter [The Eppendorf Schizophrenia Inventory (ESI). Development and evaluation of a questionnaire for the measurement of characteristic experiences of cognitive dysfunctions of schizophrenic subjects].” Nervenarzt 71 (11): 885–892.
   PubMed Web of Science ®Google Scholar
• Miller, T. J., D. Cicchetti, P. J. Markovich, T. H. McGlashan, and S. W. Wood. 2004. “The SIPS Screen: A Brief Self-report Screen to Detect the Schizophrenia Prodrome.” Schizophrenia Research 70 (Suppl.): 78.
   Google Scholar
• Mossaheb, N., J. Becker, M. R. Schaefer, C. M. Klier, M. Schloegelhofer, K. Papageorgiou, and G. P. Amminger. 2012. “The Community Assessment of Psychic Experience (CAPE) Questionnaire as a Screening-instrument in the Detection of Individuals at Ultra-High Risk for Psychosis.” Schizophrenia Research 141 (2–3): 210–214.
   PubMed Web of Science ®Google Scholar
• Mrazek, P. J., R. J. Haggerty. 1994. Reducing Risk for Mental Disorders: Frontiers for Preventive Intervention Research. Washington, DC: National Academy Press.
   Google Scholar
• Ochoa, S., J. M. Haro, J. V. Torres, A. Pinto-Meza, C. Palacín, M. Bernal, T. Brugha, et al. 2008. “What is the Relative Importance of Self Reported Psychotic Symptoms in Epidemiological Studies? Results from the ESEMeD–Catalonia Study.” Schizophrenia Research 102 (1–3): 261–269.10.1016/j.schres.2008.04.010
   PubMed Web of Science ®Google Scholar
• Schaffner, N., B. G. Schimmelmann, A. Niedersteberg, and F. Schultze-Lutter. 2012. “Versorgungswege von erstmanifesten psychotischen Patienten – eine Übersicht internationaler Studien [Pathways-to-Care for First-Episode Psychotic Patients – An Overview of International Studies].” Fortschritte Der Neurologie, Psychiatrie 80 (02): 72–78.10.1055/s-0031-1273428
   PubMed Web of Science ®Google Scholar
• Schmidt, S. J., F. Schultze-Lutter, B. G. Schimmelmann, N. P. Maric, R. K. R. Salokangas, A. Riecher-Rössler, M. van der Gaag, et al. 2015. “EPA Guidance on the Early Intervention in Clinical High Risk States of Psychoses.” European Psychiatry 30 (3): 388–404.10.1016/j.eurpsy.2015.01.013
   PubMed Web of Science ®Google Scholar
• Schultze-Lutter, F. 2009. “Subjective Symptoms of Schizophrenia in Research and the Clinic: The Basic Symptom Concept.” Schizophrenia Bulletin 35 (1): 5–8.10.1093/schbul/sbn139
   PubMed Web of Science ®Google Scholar
• Schultze-Lutter, F., J. Addington, S. Ruhrmann, and J. Klosterkötter. 2007. Schizophrenia Proneness Instrument, Adult Version (SPI-a). Rome: Giovanni Fioriti Editore s.l.r.
   Google Scholar
• Schultze-Lutter, F., S. Ruhrmann, J. Berning, W. Maier, and J. Klosterkötter. 2010. “Basic Symptoms and Ultrahigh Risk Criteria: Symptom Development in the Initial Prodromal State.” Schizophrenia Bulletin 36 (1): 182–191.10.1093/schbul/sbn072
   PubMed Web of Science ®Google Scholar
• Schultze-Lutter, F., M. Marshall, and E. Koch. 2012a. Schizophrenia Proneness Instrument, Child and Youth Version; Extended English Translation (SPI-CY EET). Rome: Giovanni Fioriti Editore s.l.r.
   Google Scholar
• Schultze-Lutter, F., S. Ruhrmann, P. Fusar-Poli, A. Bechdolf, B. G. Schimmelmann, and J. Klosterkötter. 2012b. “Basic Symptoms and the Prediction of First-episode Psychosis.” Current Pharmaceutical Design 18 (4): 351–357.10.2174/138161212799316064
   PubMed Web of Science ®Google Scholar
• Schultze-Lutter, F., B. G. Schimmelmann, S. Ruhrmann, and C. Michel. 2013. “‘A Rose is a Rose is a Rose’, but at-risk Criteria Differ.” Psychopathology 46 (2): 75–87.10.1159/000339208
   PubMed Web of Science ®Google Scholar
• Schultze-Lutter, F., F. Renner, J. Paruch, D. Julkowski, J. Klosterkötter, and S. Ruhrmann. 2014. “Self-reported Psychotic-like Experiences Are a Poor Estimate of Clinician-rated Attenuated and Frank Delusions and Hallucinations.” Psychopathology 47 (3): 194–201.10.1159/000355554
   PubMed Web of Science ®Google Scholar
• Schultze-Lutter, F., C. Michel, S. J. Schmidt, B. G. Schimmelmann, N. P. Maric, R. K. R. Salokangas, A. Riecher-Rössler, et al. 2015. “EPA Guidance on the Early Detection of Clinical High Risk States of Psychoses.” European Psychiatry 30 (3): 405–416.10.1016/j.eurpsy.2015.01.010
   PubMed Web of Science ®Google Scholar
• Sheehan, D. V., Y. Lecrubier, K. H. Sheehan, P. Amorim, J. Janavs, E. Weiller, T. Hergueta, R. Baker, and G. C. Dunbar. 1998. “The Mini-International Neuropsychiatric Interview (M.I.N.I.): The Development and Validation of a Structured Psychiatric Interview for DSM-IV and ICD-10.” Journal of Clinical Psychiatry 59 (Suppl 20): 22-34.
   PubMed Web of Science ®Google Scholar
• Sim, J., and C. C. Wright. 2005. “The Kappa Statistic in Reliability Studies: Use, Interpretation, and Sample Size Requirements.” Physical Therapy 85 (3): 257–268.
   PubMed Web of Science ®Google Scholar
• Stefanis, N. C., M. Hanssen, N. K. Smirnis, D. A. Avramopoulos, I. K. Evdokimidis, C. N. Stefanis, H. Verdoux, and J. Van Os. 2002. “Evidence That Three Dimensions of Psychosis Have a Distribution in the General Population.” Psychological Medicine 32 (02): 347–358.10.1017/S0033291701005141
   PubMed Web of Science ®Google Scholar
• Stinson, J. N., T. Kavanagh, J. Yamada, N. Gill, and B. Stevens. 2006. “Systematic Review of the Psychometric Properties, Interpretability and Feasibility of Self-report Pain Intensity Measures for Use in Clinical Trials in Children and Adolescents.” Pain 125 (1): 143–157.10.1016/j.pain.2006.05.006
   PubMed Web of Science ®Google Scholar
• Süllwold, L. 1991. Manual zum Frankfurter Beschwerde-Fragebogen (FBF) [Manual of the Frankfurt Complaint Questionnaire (FCQ)]. Berlin: Springer.10.1007/978-3-642-58209-7
   Google Scholar
• Süllwold, L., and G. Huber. 1986. Schizophrene Basisstörungen. Monographien aus dem Gesamt Gebiete der Psychiatrie, Bd.42. [Schizophrenic basic disorders: Monographs from the entire field of psychiatry] Berlin: Springer.
   Google Scholar
• Tandon, N., J. Shah, M. S. Keshavan, and R. Tandon. 2012. “Attenuated Psychosis and the Schizophrenia Prodrome: Current Status of Risk Identification and Psychosis Prevention.” Neuropsychiatry 2 (4): 345–353.10.2217/npy.12.36
   PubMed Web of Science ®Google Scholar
• Yon, V., G. Loas, and J. L. Monestès. 2008. “Dimensional Structure of the Frankfurt Complaint Questionnaire in a Sample of French Students.” Psychopathology 41 (2): 85–89.10.1159/000111552
   PubMed Web of Science ®Google Scholar
• Yung, A. R., B. Nelson, K. Baker, J. A. Buckby, G. Baksheev, and E. M. Cosgrave. 2009. “Psychotic-like Experiences in a Community Sample of Adolescents: Implications for the Continuum Model of Psychosis and Prediction of Schizophrenia.” Australian and New Zealand Journal of Psychiatry 43 (2): 118–128.10.1080/00048670802607188
   PubMed Web of Science ®Google Scholar